missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human IFN-alpha B2/IFNA8 Protein
Click to view available options
Menge:
10 μg
50 μg
Packungsgröße:
10 Mikrogramm
50 Mikrogramm
Beschreibung
Measured in anti-viral assays using HeLa human cervical epithelial carcinoma cells infected with encephalomyocarditis (EMC) virus. Meager, A. (1987) in Lymphokines and Interferons, a Practical Approach. Clemens, M.J. et al. (eds): IRL Press. 129. The ED50 for this effect is 1.20-12.0 pg/mL.
Spezifikation
Spezifikation
| Zugriffsnummer | P32881.1 |
| Zur Verwendung mit (Anwendung) | Bioactivity |
| Zusammensetzung | Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. |
| Gen-ID (Entrez) | 3445 |
| Molekulargewicht | MolecularWeight-observed: 23-27 kDa, under reducing conditions.; MolecularWeight-theroretical: 19 kDa |
| Menge | 10 μg |
| Quelle | Human embryonic kidney cell, HEK293-derived IFN-alpha B2/IFNA8 protein Cys24-Glu189 |
| Lagerungsbedingungen | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. |
| Endotoxin-Konzentration | <0.10 EU / 1 μg of the protein by the LAL method. |
| Gen-Alias | IFNA8, IFNalpha B2, IFN-alpha B2, IFN-alpha-8, IFN-alphaB, interferon alpha type 201, interferon alpha-8, interferon alpha-B', Interferon alpha-B, Interferon alpha-B2, interferon, alpha 8, LeIF B |
| Mehr anzeigen |
Berichtigung von Produktinhalten
Bitte geben Sie uns Ihr Feedback zu den Produktinhalten, indem Sie das folgende Formular ausfüllen.
Name des Produkts
Haben Sie Verbesserungsvorschläge?Übermitteln Sie eine inhaltliche Korrektur